However, the timeline of metabolic improvement may not align with immediate symptomatic relief, and some patients may experience a temporary dip in wellbeing during the adjustment period
Rebound effects of modern drugs: serious adverse events unknown by health professionals
238 Recent advancements in toxicity prediction using 3D liver cell models and integrated herbal safety databases are steps toward modernizing herbal pharmacovigilance
The emergence of tirzepatide, a dual incretin receptor agonist targeting both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, presents major therapeutic potential for MASLD
What is GLP-1 GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone in the body playing an important role in sugar metabolism
[DOI] [PubMed] [Google Scholar] 25.Muskiet MHA, Tonneijck L, Smits MM, et al